1. Signaling Pathways
  2. Cytoskeleton
  3. Myosin

Myosin (肌球蛋白)

Myosins are mechanoenzymes that interact with actin filaments and hydrolyse ATP to generate movement and force. This enables myosins to propel the sliding of actin filaments, to produce tension on actin filaments and to walk along these filaments. As a result, myosins can regulate the structure and dynamics of the actin cytoskeleton and affect the localization and transport of cellular components. The different myosins are grouped into classes on the basis of their motor domains. There are 35 known classes of myosin, and humans have 40 myosin genes that fall into 13 classes (I, II, III, V, VI, VII, IX, X, XV, XVI, XVIII, XIX and XXXV).

Myosins are actin-dependent motors that participate in a diverse range of crucial activities, including muscle contraction, intracellular trafficking, cell division, motility, actin cytoskeletal organisation and cell signaling. Myosin malfunction has been implicated in a variety of disorders including deafness, hypertrophic cardiomyopathy, Usher syndrome, Griscelli syndrome and cancer.

Myosin light chain kinase (MLCK) is an enzyme that activates the myosin light chain to exert its function related to cytoskeleton contraction and tight junction regulation. In most cells, MLCK is a transducer for signalling MLC phosphorylation in response to Ca2+ binding to MLCK-associated calmodulin. MLCK-mediated MLC phosphorylation and actomyosin contractility is important in muscle contraction, cell migration, and endo/exocytic processes, and is recognized for its central role in signalling endothelial cell-cell adhesion and barrier function.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-141810
    MT-134 Inhibitor
    MT-134 是一种 SkMII 特异性抑制剂,在肌肉中具有良好的暴露性。
    MT-134
  • HY-100984A
    HA-100 hydrochloride Inhibitor
    HA-100 hydrochloride 是一种有效的蛋白激酶抑制剂,抑制 PKGPKAPKCMLC 激酶的 IC50 值分别为 4 μM、8 μM、12 μM 和 240 μM。HA-100 hydrochloride 也用作 ROCK 抑制剂。
    HA-100 hydrochloride
  • HY-14233S
    Omecamtiv mecarbil-d8 Activator
    Omecamtiv mecarbil-d8 是 Omecamtiv mecarbil 的氘代物。Omecamtiv mecarbil (CK-1827452) 是一种心脏特异性的肌球蛋白 (cardiac myosin) 激活剂。
    Omecamtiv mecarbil-d<sub>8</sub>
  • HY-161609
    Myosin modulator 2 Modulator
    Myosin modulator 2 (Compound B172) 是肌球蛋白 (myosin) 调节剂,可抑制兔腰大肌、猪心房和猪心室中的 ATP 酶,IC25 分别为 2.013、2.94 和 20.93 μM。Myosin modulator 2 调节 Sprague Dawley 大鼠的心脏收缩性能。
    Myosin modulator 2
  • HY-13441G
    (-)-Blebbistatin (GMP) Inhibitor
    (-)-Blebbistatin (GMP) 是 GMP 级别的 (-)-Blebbistatin (HY-13441)。(-)-Blebbistatin (GMP) 是选择性的非肌肉肌球蛋白 II (myosin II) ATPase 活性的抑制剂。
    (-)-Blebbistatin (GMP)
  • HY-163120
    Myosin-IN-1 Inhibitor
    Myosin-IN-1 (compound F10) 是 Myosin 抑制剂,特异性靶向心脏肌球蛋白。Myosin-IN-1 可稳定心肌肌球蛋白运动域的生化和结构关闭状态,并在体外降低心肌的力产生和钙敏感性。Myosin-IN-1 在离体 Langendroff 灌注的大鼠心脏中充当负性肌力剂,减少分离肌丝中的应力和左心室压力发展。Myosin-IN-1 可用于心力衰竭的研究。
    Myosin-IN-1
  • HY-123326
    KT5926 Inhibitor
    KT5926 是一种有效的选择性肌球蛋白轻链激酶抑制剂,可抑制病毒的初级和次级转录和基因组 RNA 合成。
    KT5926
  • HY-109037S2
    Mavacamten-d1 Modulator
    Mavacamten-d1 (MYK461-d1; SAR439152-d1) 是氘代标记的 Mavacamten (HY-109037)。Mavacamten (MYK461) 是具有口服活性的心肌肌球蛋白的调节剂,其在牛心脏和人心脏中的 IC50 值分别为 490,711 nM。
    Mavacamten-d<sub>1</sub>
  • HY-109037R
    Mavacamten (Standard) Modulator
    Mavacamten (Standard)是 Mavacamten 的分析标准品。本产品用于研究及分析应用。Mavacamten (MYK461) 是具有口服活性的心肌肌球蛋白的调节剂,其在牛心脏和人心脏中的 IC50 值分别为 490,711 nM。
    Mavacamten (Standard)
  • HY-109037S
    Mavacamten-d6 Modulator
    Mavacamten-d6 (MYK461-d6; SAR439152-d6) 是氘代标记的 Mavacamten (HY-109037)。Mavacamten (MYK461) 是具有口服活性的心肌肌球蛋白的调节剂,其在牛心脏和人心脏中的 IC50 值分别为 490,711 nM。
    Mavacamten-d<sub>6</sub>
  • HY-159821
    Ulacamten Inhibitor
    Ulacamten 是一种有效的心脏肌球蛋白 (cardiac myosin) 抑制剂。
    Ulacamten
目录号 产品名 / 同用名 应用 反应物种